Keywords: Alzheimer, S Disease, Flumazenil Pet, Gaba A Receptors, 4 Aminobutyric Acid A Receptor, Flumazenil C 11, Fluorodeoxyglucose F 18, Aged, Alzheimer Disease, Article, Autopsy, Brain Metabolism, Brain Region, Brain Size, Cell Loss, Clinical Article, Controlled Study, Female, Hippocampus, Human, In Vivo Study, Inferior Temporal Cortex, Memory, Nerve Cell, Neuroimaging, Nuclear Magnetic Resonance Imaging, Positron Emission Tomography, Posterior Cingulate, Priority Journal, Receptor Binding, Retrosplenial Cortex, Voxel Based Morphometry, 80 And Over, Carbon Radioisotopes, Ligands, Neuropsychological Tests, Positron-Emission Tomography, Diagnosis, Diagnostic Imaging, Pharmacokinetics,
Affiliations: *** IBB - CNR ***
Neuroscience Division, Centre for Applied Medical Research, University of Navarra, Pamplona, 31008, Spain
CIBERNED, Pamplona, 31008, Spain
Department of Nuclear Medicine, University of Navarra, Pamplona, 31008, Spain
Department of Anaesthesiology and Critical Care, University of Navarra, Pamplona, 31008, Spain
Institute of Biostructure and Bioimaging, Consiglio Nazionale Delle Ricerche, Naples, 80131, Italy
References: Armstrong, D.M., Sheffield, R., Mishizen-Eberz, A.J., Carter, T.L., Rissman, R.A., Mizukami, K., Plasticity of glutamate and GABAA receptors in the hippocampus of patients with Alzheimer's disease (2003) Cell Mol Neurobiol, 23, pp. 491-50
Ashburner, J., A fast diffeomorphic image registration algorithm (2007) Neuroimage, 38, pp. 95-113
Berkouk, K., Quarantelli, M., Prinster, A., Landeau, B., Alfano, B., Baron, J.C., Mapping the relative contribution of gray matter activity vs. volume in brain PET: A new approach (2006) J Neuroimaging, 16, pp. 224-235
Brun, A., Englund, E., Regional pattern of degeneration in Alzheimer's disease: Neuronal loss and histopathological grading (1981) Histopathology, 5, pp. 549-564
Chen, K., Ayutyanont, N., Langbaum, J.B., Fleisher, A.S., Reschke, C., Lee, W., Characterizing alzheimer's disease using a hypometabolic convergence index (2011) Neuroimage, 56, pp. 52-60
Chetelat, G., Desgranges, B., Landeau, B., Mezenge, F., Poline, J.B., De La Sayette, V., Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease (2008) Brain, 131, pp. 60-71
Chetelat, G., Villemagne, V.L., Bourgeat, P., Pike, K.E., Jones, G., Ames, D., Relationship between atrophy and beta-amyloid deposition in alzheimer disease (2010) Ann Neurol, 67, pp. 317-324
Chu, D.C., Penney, Jr.J.B., Young, A.B., Cortical GABAB and GABAA receptors in Alzheimer's disease: A quantitative autoradiographic study (1987) Neurology, 37, pp. 1454-1459
Crystal, H., Dickson, D., Fuld, P., Masur, D., Scott, R., Mehler, M., Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer's disease (1988) Neurology, 38, pp. 1682-1687
Delforge, J., Pappata, S., Millet, P., Samson, Y., Bendriem, B., Jobert, A., Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol (1995) J Cereb Blood Flow Metab, 15, pp. 284-300
Fukuchi, K., Hashikawa, K., Seike, Y., Moriwaki, H., Oku, N., Ishida, M., Comparison of iodine-123-iomazenil SPECT and technetium-99 m-HMPAO-SPECT in Alzheimer's disease (1997) J Nucl Med, 38, pp. 467-470
Giannakopoulos, P., Herrmann, F.R., Bussiere, T., Bouras, C., Kovari, E., Perl, D.P., Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease (2003) Neurology, 60, pp. 1495-1500
Gomez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J.H., Petersen, R.C., Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease (1997) Ann Neurol, 41, pp. 17-24
Gomez-Isla, T., Price, J.L., McKeel, Jr.D.W., Morris, J.C., Growdon, J.H., Hyman, B.T., Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease (1996) J Neurosci, 16, pp. 4491-4500
Hammers, A., Panagoda, P., Heckemann, R.A., Kelsch, W., Turkheimer, F.E., Brooks, D.J., [11C]Flumazenil PET in temporal lobe epilepsy: Do we need an arterial input function or kinetic modeling? (2008) J Cereb Blood Flow Metab, 28, pp. 207-216
Heiss, W.D., Sobesky, J., Smekal, U., Kracht, L.W., Lehnhardt, F.G., Thiel, A., Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: A comparative positron emission tomography/magnetic resonance imaging study in early is-chemic stroke (2004) Stroke, 35, pp. 1892-1898
Innis, R.B., Cunningham, V.J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R.N., Consensus nomenclature for in vivo imaging of reversibly binding radioligands (2007) J Cereb Blood Flow Metab, 27, pp. 1533-1539
Iwakiri, M., Mizukami, K., Ikonomovic, M.D., Ishikawa, M., Abrahamson, E.E., Dekosky, S.T., An immunohistochemical study of GABA A receptor gamma subunits in Alzheimer's disease hippocampus: Relationship to neurofibrillary tangle progression (2009) Neuropathology, 29, pp. 263-269
Jansen, K.L., Faull, R.L., Dragunow, M., Synek, B.L., Alzheimer's disease: Changes in hippocampal N-methyl-D-aspartate, quisqualate, neuroten-sin, adenosine, benzodiazepine, serotonin and opioid receptors-an autoradiographic study (1990) Neuroscience, 39, pp. 613-627
Kalbe, E., Kessler, J., Calabrese, P., Smith, R., Passmore, A.P., Brand, M., DemTect: A new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia (2004) Int J Geriatr Psychiatry, 19, pp. 136-143
Killiany, R.J., Gomez-Isla, T., Moss, M., Kikinis, R., Sandor, T., Jolesz, F., Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease (2000) Ann Neurol, 47, pp. 430-439
Kisvarday, Z.F., Gulyas, A., Beroukas, D., North, J.B., Chubb, I.W., Somogyi, P., Synapses, axonal and dendritic patterns of GABA-immunoreactive neurons in human cerebral cortex (1990) Brain, 113 (PART 3), pp. 793-812
Klumpers, U.M., Boellaard, R., Veltman, D.J., Kloet, R.W., Hoogendijk, W.J., Lammertsma, A.A., Parametric [11c]flumazenil images (2012) Nucl Med Commun, 33, pp. 422-430
Klumpers, U.M., Veltman, D.J., Boellaard, R., Comans, E.F., Zuketto, C., Yaqub, M., Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies (2008) J Cereb Blood Flow Metab, 28, pp. 579-587
La Fougere, C., Grant, S., Kostikov, A., Schirrmacher, R., Gravel, P., Schipper, H.M., Where In-vivo imaging meets cytoarchitectonics: The relationship between cortical thickness and neuronal density measured with high-resolution [f-18]flumazenil-pet (2011) Neuroimage, 56, pp. 951-960
Lavenex, P., Suzuki, W.A., Amaral, D.G., Perirhinal and parahippocampal cortices of the macaque monkey: Projections to the neocortex (2002) J Comp Neurol, 447, pp. 394-420
Massaweh, G., Schirrmacher, E., La Fougere, C., Kovacevic, M., Wangler, C., Jolly, D., Improved work-up procedure for the production of [(18)F]flumazenil and first results of its use with a high-resolution research tomograph in human stroke (2009) Nucl Med Biol, 36, pp. 721-727
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M., Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease (1984) Neurology, 34, pp. 939-944
Meyer, M., Koeppe, R.A., Frey, K.A., Foster, N.L., Kuhl, D.E., Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease (1995) Arch Neurol, 52, pp. 314-317
Misra, C., Fan, Y., Davatzikos, C., Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI (2009) Neuroimage, 44, pp. 1415-1422
Mourik, J.E., Lubberink, M., Klumpers, U.M., Comans, E.F., Lammertsma, A.A., Boellaard, R., Partial volume corrected image derived input functions for dynamic PET brain studies: Methodology and validation for [11C]flumazenil (2008) Neuroimage, 39, pp. 1041-1050
Munoz, M., Insausti, R., Cortical efferents of the entorhinal cortex and the adjacent parahippocampal region in the monkey (Macaca fascicularis) (2005) Eur J Neurosci, 22, pp. 1368-1388
Ohyama, M., Senda, M., Ishiwata, K., Kitamura, S., Mishina, M., Ishii, K., Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF (1999) Ann Nucl Med, 13, pp. 309-315
Okazawa, H., Yamauchi, H., Sugimoto, K., Magata, Y., Kudo, T., Yonekura, Y., Effects of metabolite correction for arterial input function on quantitative receptor images with 11C-flumazenil in clinical positron emission tomography studies (2004) J Comput Assist Tomogr, 28, pp. 428-435
Pappata, S., Varrone, A., Vicidomini, C., Milan, G., De Falco, C., Sansone, V., SPECT imaging of GABA(A)/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment (2010) Eur J Nucl Med Mol Imaging, 37, pp. 1156-1163
Pascual, B., Prieto, E., Arbizu, J., Marti-Climent, J., Olier, J., Masdeu, J.C., Brain glucose metabolism in vascular white matter disease with dementia: Differentiation from alzheimer disease (2010) Stroke, 41, pp. 2889-2893
Petersen, R.C., Mild cognitive impairment as a diagnostic entity (2004) J Intern Med, 256, pp. 183-194
Prieto, E., Marti-Climent, J.M., Arbizu, J., Garrastachu, P., Dominguez, I., Quincoces, G., Evaluation of spatial resolution of a pet scanner through the simulation and experimental measurement of the recovery coefficient (2010) Comp Biol Med, 40, pp. 75-80
Quarantelli, M., Berkouk, K., Prinster, A., Landeau, B., Svarer, C., Balkay, L., Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction (2004) J Nucl Med, 45, pp. 192-201
Rissman, R.A., Bennett, D.A., Armstrong, D.M., Subregional analysis of GABA(A) receptor subunit mRNAs in the hippocampus of older persons with and without cognitive impairment (2004) J Chem Neuroanat, 28, pp. 17-25
Rocher, A.B., Chapon, F., Blaizot, X., Baron, J.C., Chavoix, C., Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: A study in baboons (2003) Neuroimage, 20, pp. 1894-1898
Rousset, O.G., Ma, Y., Evans, A.C., Correction for partial volume effects in PET: Principle and validation (1998) J Nucl Med, 39, pp. 904-911
Sedvall, G., Nyback, H., Farde, L., Persson, A., Neurotransmitter receptor imaging in Alzheimer's disease (1987) J Neural Transm Suppl, 24, pp. 43-48
Shimohama, S., Taniguchi, T., Fujiwara, M., Kameyama, M., Changes in benzodiazepine receptors in Alzheimer-type dementia (1988) Ann Neurol, 23, pp. 404-406
Soricelli, A., Postiglione, A., Grivet-Fojaja, M.R., Mainenti, P.P., Discepolo, A., Varrone, A., Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer's disease as a measure of loss of synapses (1996) Eur J Nucl Med, 23, pp. 1323-1328
Armstrong, D. M., Sheffield, R., Mishizen-Eberz, A. J., Carter, T. L., Rissman, R. A., Mizukami, K., Plasticity of glutamate and GABAA receptors in the hippocampus of patients with Alzheimer's disease (2003) Cell Mol Neurobiol, 23, pp. 491-50
Chu, D. C., Penney, Jr. J. B., Young, A. B., Cortical GABAB and GABAA receptors in Alzheimer's disease: A quantitative autoradiographic study (1987) Neurology, 37, pp. 1454-1459
Heiss, W. D., Sobesky, J., Smekal, U., Kracht, L. W., Lehnhardt, F. G., Thiel, A., Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: A comparative positron emission tomography/magnetic resonance imaging study in early is-chemic stroke (2004) Stroke, 35, pp. 1892-1898
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Consensus nomenclature for in vivo imaging of reversibly binding radioligands (2007) J Cereb Blood Flow Metab, 27, pp. 1533-1539
Jansen, K. L., Faull, R. L., Dragunow, M., Synek, B. L., Alzheimer's disease: Changes in hippocampal N-methyl-D-aspartate, quisqualate, neuroten-sin, adenosine, benzodiazepine, serotonin and opioid receptors-an autoradiographic study (1990) Neuroscience, 39, pp. 613-627
Killiany, R. J., Gomez-Isla, T., Moss, M., Kikinis, R., Sandor, T., Jolesz, F., Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease (2000) Ann Neurol, 47, pp. 430-439
Kisvarday, Z. F., Gulyas, A., Beroukas, D., North, J. B., Chubb, I. W., Somogyi, P., Synapses, axonal and dendritic patterns of GABA-immunoreactive neurons in human cerebral cortex (1990) Brain, 113 (PART 3), pp. 793-812
Klumpers, U. M., Boellaard, R., Veltman, D. J., Kloet, R. W., Hoogendijk, W. J., Lammertsma, A. A., Parametric [11c] flumazenil images (2012) Nucl Med Commun, 33, pp. 422-430
Klumpers, U. M., Veltman, D. J., Boellaard, R., Comans, E. F., Zuketto, C., Yaqub, M., Comparison of plasma input and reference tissue models for analysing [(11) C] flumazenil studies (2008) J Cereb Blood Flow Metab, 28, pp. 579-587
Mourik, J. E., Lubberink, M., Klumpers, U. M., Comans, E. F., Lammertsma, A. A., Boellaard, R., Partial volume corrected image derived input functions for dynamic PET brain studies: Methodology and validation for [11C] flumazenil (2008) Neuroimage, 39, pp. 1041-1050
Petersen, R. C., Mild cognitive impairment as a diagnostic entity (2004) J Intern Med, 256, pp. 183-194
Rissman, R. A., Bennett, D. A., Armstrong, D. M., Subregional analysis of GABA (A) receptor subunit mRNAs in the hippocampus of older persons with and without cognitive impairment (2004) J Chem Neuroanat, 28, pp. 17-25
Rocher, A. B., Chapon, F., Blaizot, X., Baron, J. C., Chavoix, C., Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: A study in baboons (2003) Neuroimage, 20, pp. 1894-1898
Rousset, O. G., Ma, Y., Evans, A. C., Correction for partial volume effects in PET: Principle and validation (1998) J Nucl Med, 39, pp. 904-911
Shan, Z. Y., Mateja, S. J., Reddick, W. E., Glass, J. O., Shulkin, B. L., Retrospective evaluation of PET-MRI registration algorithms (2011) J Digit Imaging, 24, pp. 485-493
Decreased carbon-11-flumazenil binding in early Alzheimer's disease